Amicus Therapeutics continues soaring By: MarketMinute.com Stock News August 27, 2014 at 17:30 PM EDT Shares of Amicus Therapeutics Inc. (Nasdaq: FOLD) continued soaring by gaining 64 cents to close at $6.84 after reporting successful late stage trial results last week. Related Stocks: Amicus Therapeutics